Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Gnant, M; Jakesz, R; Mlineritsch, B; Luschin-Ebengreuth, G; Schmid, M; Menzel, C; Kubista, E; Samonigg, H; Hausmaninger, H.
Zoledronic acid effectively counteracts cancer treatment induced bone loss (CTIBL) in premenopausal breast cancer patients receiving adjuvant endocrine treatment with goserelin plus anastrozole versus goserelin plus tamoxifen - bone density subprotocol results of a randomized multicenter trial (ABCSG-12)
BREAST CANCER RES TREAT. 2004; 88: S8-S9.
Web of Science

 

Autor*innen der Med Uni Graz:
Luschin-Ebengreuth Gero
Samonigg Hellmut
Altmetrics:


© Med Uni Graz • Impressum